A phase I study of irinotecan and infusional cisplatin with recombinant human granulocyte colony-stimulating factor support in the treatment of advanced non-small cell lung cancer

European Journal of Cancer Part A

Volumn 33, Issue 3, 1997, Pages 503-505

  Mori, K ^a   Hirose, T ^a   Machida, S ^a   Yokoyama, K ^a   Tominaga, K ^a  

^a TOCHIGI CANCER CENTER   (Japan)

Author keywords

cisplatin; irinotecan; non small cell lung cancer; phase I study; rG CSF

Indexed keywords

CISPLATIN; IRINOTECAN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DIARRHEA; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MALE; NEUTROPENIA; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0031106353     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(97)89030-2     Document Type: Article

References (7)

1. Mori K, Ohnishi T, Yokoyama K, Tominaga K. A phase I study of irinotecan and infusional cisplatin for advanced non-small cell lung cancer. Cancer Chemother Pharmacol, in press.
2. Negoro S, Fukuoka M, Masuda N, et al. Phase I study of weekly administration of CPT-11. J Natl Cancer Inst. 83:1991;1164-1168.
3. Frei E, Canellos GP. Dose: a critical factor in cancer chemotherapy. Am J Med. 69:1980;585-594.
4. Masuda N, Fukuoka M, Kudoh S, et al. Phase I study of irinotecan and cisplatin with granulocyte colony-stimulating factor support for advanced non-small-cell lung cancer. J Clin Oncol. 12:1994;90-96.
5. Ruckdeschel JC. Chemotherapy of metastatic non-small cell carcinoma of the lung. Hematol Oncol. 10:1992;25-30.
6. Masuda N, Fukuoka M, Takada M, et al. CPT-11 in combination with cisplatin for advanced non-small-cell lung cancer. J Clin Oncol. 10:1992;1775-1780.
7. Masuda N, Fukuoka M, Kudoh S, et al. Phase I and pharmacologic study of irinotecan in combination with cisplatin for advanced lung cancer. Br J Cancer. 68:1993;777-782.